RNA, U6 small nuclear 1310, pseudogene (RNU6-1310P)

RNU6-1310P (RNA, U6 small nuclear 1310, pseudogene) is a pseudogene of the U6 small nuclear RNA (snRNA) family[4]. U6 snRNA itself is an essential component of the spliceosome, the ribonucleoprotein complex responsible for excision of introns from pre-mRNA during mRNA splicing[1][3]. However, RNU6-1310P does not produce a functional RNA; it is classified as a pseudogene, which means it represents a nonfunctional remnant of a once-active U6 snRNA gene. U6 snRNA pseudogenes are commonly found throughout mammalian and vertebrate genomes due to retrotransposition and other genomic duplication events[2][4]. These pseudogenes do not participate in biological processes such as splicing and have no known role as a therapeutic target, biomarker, or drug interaction partner[2][5][4]. Their presence in the genome may serve as markers of retrotransposition activity but does not confer any canonical molecular or therapeutic function[2]. Note: - This target is not considered a therapeutic or drug target; it is a non-functional pseudogene[4]. - There is nothing functionally relevant about this "target" in drug discovery or disease; it does not encode a protein, receptor, enzyme, or regulatory RNA[2][4]. - The entry itself is correctly named and classified as a pseudogene, but for most drug discovery or target validation workflows, such pseudogenes do not have a mechanistic or biological function[4]. Summary: RNU6-1310P is a correctly classified, nonfunctional RNA pseudogene, not a biological or therapeutic target.

Other names

RNU6-1310PRNA U6-1310 pseudogene